Navigation Links
Remedy Informatics Joins LongView International Technology Solutions Team to Win CIO-SP3 Contract Award
Date:7/17/2012

SALT LAKE CITY, July 17, 2012 /PRNewswire/ --  Remedy Informatics, Inc., the leading provider of registries and research informatics software for Life Science, Translational and Biomedical Research and Healthcare, today announced it is a key member of the LongView International Technology Solutions team awarded a prime contract by the National Institutes of Health (NIH) Information Technology Acquisition and Assessment (NITAAC). The CIO-SP3 contract provides for the delivery of a broad range of IT services and solutions for the Institutes and Centers of the NIH, the Department of Health and Human Services (HHS) and other federal departments.

(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)

"We are thrilled to partner with LongView and our other team members to provide high quality, enterprise-level biomedical informatics and IT solutions to government agencies," said Gary Kennedy, Founder and CEO of Remedy Informatics. "The CIO-SP3 contract is an extremely important initiative because it will allow agencies throughout NIH and HHS that are responsible for leading key research initiatives to more quickly deploy new technologies that will enable them to accelerate the pace of medical discoveries and innovation."

Remedy was chosen for its expertise in patient registries, integrated research management systems, and new technology for aggregating, mapping and harmonizing biomedical research data. With several high profile research institutions currently using Remedy's products, including Massachusetts General Hospital, the American Joint Replacement Registry, the Oklahoma Medical Research Foundation, and many others, Remedy is poised to offer its next-generation registry and research informatics technology to government agencies and departments facing biomedical data challenges.

Buil
'/>"/>

SOURCE Remedy Informatics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The Jewish Hospital - Mercy Health Selects Remedy Informatics ComprehensiveBMT Product
2. Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software at ISBER 2012 Annual Meeting
3. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
4. Remedy Informatics Cardiovascular Registry Selected by World-Renowned Cleveland Clinic Heart and Vascular Institute
5. Tara Dall, MD Joins Health Diagnostic Laboratory (HDL, Inc.) as Chief Medical Officer
6. Double Helix Joins McCann Health
7. Prairie Education & Research Cooperative Joins MedNet Solutions iMedNet CRO Partner Program
8. Don Hubbard Joins Checkpoint Surgical As VP Of Sales And Marketing
9. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
10. American Society of Hematology joins European Hematology Association, Patient Groups in Issuing International Call to Action to Alleviate Drug Shortages
11. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015  IDEXX Laboratories, Inc. (NASDAQ: IDXX ) ... of $413 million, an increase of 6% compared to ... the US dollar reduced reported revenue growth by 7%. ... was 11%, supported by strong growth in the Companion ... ("EPS") was $0.60 for the quarter, an increase of ...
(Date:7/29/2015)... 2015  Astellas today announced topline results from ... and safety of intravenous (IV) and oral isavuconazole, ... for adults with candidemia and other invasive ... that the trial did not meet its primary ... isavuconazole-treated patients at the end of IV therapy ...
(Date:7/29/2015)... , July 29, 2015  Unilife Corporation ("Unilife" ... UNS), a developer, manufacturer and supplier of injectable drug ... financing strategy that provides the Company with flexibility and ... Unilife has signed an equity purchase agreement for ... LLC ("LPC"), a Chicago -based institutional ...
Breaking Medicine Technology:IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4
... - Trial Results Confirm Efficacy for Population ... N.J. and EMERYVILLE, Calif., May 16 ,Bayer ... ONXX ) today announced that Nexavar(R) ... percent (HR=0.68;,p-value=0.014) in patients in the Asia-Pacific ...
... Ovarian ... Cancers -, - Company ... SOUTH SAN FRANCISCO, Calif., May 15 Poniard,Pharmaceuticals, Inc. (Nasdaq: ... will present data from three,clinical trials of picoplatin, in various tumor types ...
Cached Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5
(Date:7/30/2015)... ... ... On July 23rd Clay Today Online reported the state of Florida ... system, which has amassed largely enough throughout the years. Florida is the third state ... recent reduction of non violent drug offender’s prison sentences, Florida is beginning to take ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Gummy ... including lip lowering, gum contouring and surgery, as well as the patented gum depigmentation ... that has made him popular with many patients from around the world. , “Like ...
(Date:7/30/2015)... ... July 30, 2015 , ... New research finds some distinct differences in the ... on the Surviving Mesothelioma website. , Researchers with the National Institutes of ... 12,000 cases of mesothelioma occurring between 1990 and 2010. Two percent of these cases ...
(Date:7/30/2015)... NEW ORLEANS (PRWEB) , ... July 30, 2015 , ... ... wellbeing and take charge of their health in his new self-help book, “ Consciously ... , Llanos’ new book promotes a simple message: “If we take responsibility for ourselves, ...
(Date:7/30/2015)... ... July 30, 2015 , ... After a three year trial designed to ... commonly known as the “bionic eye,” researchers have determined the trial to be a ... patients facing or already affected by complete vision loss as a result of Retinitis ...
Breaking Medicine News(10 mins):Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2
... support to the House of Commons vote to impose a ban ... ,A team of researchers measured the air quality, using a portable ... areas where smoking was permitted. The study revealed that the quality ... This, when inhaled, would cause harm to the health. ...
... An outbreak of cholera was first reported in the Luanda ... nearly 652 cases of cholera// and 22 cholera related deaths ... the latest health report published by the World Health Organization, ... reported over the past 24 hours. 8 municipalities have been ...
... 11-year-olds had taken a Class A drug, such as cocaine, ... taken hard drugs. There is a rise in illegal drug ... cocaine which has created a lot of trouble for the ... England's 3.4 million secondary pupils. Despite undertaking multi-million-pound campaigns such ...
... an agricultural engineer has developed a technique which uses ... serum albumin (HSA) from tobacco plants. HSA is an ... therapeutic needs. ,It is mainly used to ... attacks. It is used for haemorrhages, burns, surgical operations ...
... joined forces to create an Internet-based training programme ... degrees while continuing to work. ,The ... March, will create online courses for vets unable ... network. ,African vets urgently need extra ...
... European Breast Cancer Conference (EBCC-5) have called that patients should ... in the field. Doctors and patient groups said that women ... like Herceptin that could help prolong their survival and well ... and radiation therapy are available to women in the United ...
Cached Medicine News:Health News:Alternate ways to produce HAS from tobacco plants 2
... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...
... The LightCycler 2.0 System is the newest ... Science. This new instrument offers six detection ... 560, 610, 640, 670, and 710nm. Perform ... by air and working with glass capillaries. ...
Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
... Stratagene delivers a new standard in QPCR ... This new system offers superior performance, more ... unit, Computer system - with Windows 98SE ... Keyboard, Mouse, Premier Sound Speakers, Surge Protector ...
Medicine Products: